Editas Medicine Inc (NASDAQ: EDIT) is 11.02% higher on its value in year-to-date trading and has touched a low of $1.12 and a high of $11.58 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The EDIT stock was last observed hovering at around $1.38 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $1.41, the stock is 9.43% and -19.70% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.34 million and changing 2.17% at the moment leaves the stock -63.36% off its SMA200. EDIT registered -82.46% loss for a year compared to 6-month loss of -74.69%. The firm has a 50-day simple moving average (SMA 50) of $1.7937 and a 200-day simple moving average (SMA200) of $3.876225.
The stock witnessed a 12.80% gain in the last 1 month and extending the period to 3 months gives it a -56.07%, and is 15.57% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.35% over the week and 9.38% over the month.
Editas Medicine Inc (EDIT) has around 265 employees, a market worth around $116.39M and $61.76M in sales. Profit margin for the company is -340.96%. Distance from 52-week low is 25.89% and -87.82% from its 52-week high. The company has generated returns on investments over the last 12 months (-106.50%).
The EPS is expected to shrink by -33.69% this year.
Editas Medicine Inc (EDIT) Top Institutional Holders
312.0 institutions hold shares in Editas Medicine Inc (EDIT), with institutional investors hold 71.07% of the company’s shares. The shares outstanding are 82.54M, and float is at 81.78M with Short Float at 22.26%. Institutions hold 70.84% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 8.03 million shares valued at $37.51 million. The investor’s holdings represent 9.8032% of the EDIT Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 7.78 million shares valued at $36.34 million to account for 9.498 of the shares outstanding. The other top investors are DEEP TRACK CAPITAL, LP which holds 6.0 million shares representing 7.3225% and valued at over $28.02 million, while STATE STREET CORP holds 5.6029 of the shares totaling 4.59 million with a market value of $21.44 million.
Editas Medicine Inc (EDIT) Insider Activity
The most recent transaction is an insider sale by O’Neill Gilmore Neil, the company’s CEO. SEC filings show that O’Neill Gilmore Neil sold 1,618 shares of the company’s common stock on Dec 03 ’24 at a price of $2.08 per share for a total of $3361.0. Following the sale, the insider now owns 0.31 million shares.
Editas Medicine Inc disclosed in a document filed with the SEC on Dec 03 ’24 that Mei Baisong (EVP, CHIEF MEDICAL OFFICER) sold a total of 541 shares of the company’s common stock. The trade occurred on Dec 03 ’24 and was made at $2.08 per share for $1124.0. Following the transaction, the insider now directly holds 0.13 million shares of the EDIT stock.
Still, SEC filings show that on Sep 04 ’24, Mei Baisong (EVP, CHIEF MEDICAL OFFICER) disposed off 518 shares at an average price of $3.42 for $1774.0. The insider now directly holds 133,895 shares of Editas Medicine Inc (EDIT).
